Thyroid-disrupting chemicals: Interpreting upstream biomarkers of adverse outcomes

Environmental Health Perspectives

Volumn 117, Issue 7, 2009, Pages 1033-1041

  Miller, Mark D ^a,b   Crofton, Kevin M ^c   Rice, Deborah C ^d   Zoeller, R Thomas ^e  

^a CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d Maine Centers for Disease Control and Prevention   (United States)

^e UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Children's health; Endocrine disruption; Hazard identification; Risk assessment; Science policy; Thyroid hormone; Toxicologic assessments

Indexed keywords

BIOLOGICAL MARKER; ENDOCRINE DISRUPTOR; ENVIRONMENTAL CHEMICAL; THYROID HORMONE; THYRONINE; THYROTROPIN; XENOBIOTIC AGENT;

ADVERSE OUTCOME; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DEATH; HIGH RISK POPULATION; HOMEOSTASIS AND REGULATION; HORMONE ACTION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; POPULATION EXPOSURE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SOCIETY; SPECIES DIFFERENCE; THYROID DISEASE; THYROID HORMONE BLOOD LEVEL;

ANIMALS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; HUMANS; MODELS, THEORETICAL; SIGNAL TRANSDUCTION; THYROID GLAND; THYROID HORMONES;

ANIMALIA;

EID: 67650882534     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0800247     Document Type: Review

References (143)

1. Andersen S, Bruun NH, Pederson KM, Laurborg P. 2003. Biologic variation is important for interpretation of thyroid function tests. Thyroid 13(11):1069-1078.
2. Andersen S, Pedersen KM, Bruun NH, Laurberg P, 2002. Narrow individual variations in serum T(4)-and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin-Endocrinol Metab 87(3):1068-1072.
3. Aoki Y, Belin RM, Glickner R, Jeffries R, Phillips L, Mahaffey KR. 2007. Serum TS14 and total T(4) in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey INHANES 1999-2002). Thyroid 17(12):1211-1223.
4. Asvold BO, Bioro T, Nilsen TI, Vatten LJ. 2007a. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. J Clin Endocrinol Metab 92(3):841-845.
5. Asvold BO, Vatten U, Niisen TI, Bioro T. 2007b. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol 156(2):181-186.
6. Auso E, Lavado-Autric R, Cuevas E, Escobar Del Rey F, Morreale De Escobar G, Berbel P. 2004. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 145(9):4037-4047.
7. Bernal J. 2007. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab 3(3):249-259.
8. Bertrand S, Brunet FG, Escriva H. Parmentier G, Laudet V, Robinson-Rechavi M. 2004. Evolutionary genomics of nuclear receptors: from twenty-five ancestral genes to derived endocrine systems. Mol Biol Evol 21(10):1923-1937.
9. Biegel LB, Cook JC, O'Connor JC, Aschiero M, Arduengo AJ, Slone TW. 1995. Subchronic toxicity study in rats with 1-methyl-3-propylimidazole-2-thione (PTI): effects on the thyroid. Fundam Appl Toxicol 27(2):185-194.
10. Biondi B, Palmieri EA, Klein M, Schlumberger M, Filetti S, Lombardi G. 2005. Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 152(1):1-9.
11. Bizzarro MJ, Gross I. 2004, Effects of hormones on fetal lung development. Obstet Gynecol Clin North Am 31(4):949,xii.
12. Blount BC, Pirkle JL, Osterloh JD, Valentin-Blasini L, Caldwell KL. 2006. Urinary perchlorate and thyroid hormone levels in adolescent and adult men and women living in the United States. Environ Health Perspect 114:1865-1871.
13. Blumberg B, Sabbagh W Jr, Juguilon H, Bolado J Jr, van Meter CM, Ong ES, et al. 1998. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 12(20):3195-3205.
14. Boas M, Feldt-Rasmussen U, Skakkebaek NE, Main KM. 2006. Environmental chemicals and thyroid function. Eur J Endocrinol 154(5):599-611.
15. Bongers-Schokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama SM. 2000. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 136(3):292-297.
16. Brabant G, Beck-Peccoz P, Jarzab B, Laurborg P, Orgiazzi J, Szabolcs I, et al. 2006. Is there a need to redefine the upper normal limit of TSH? Eur J Enclocrinol 154(5):633-437.
17. Brucker-Davis F. 1998, Effects of environmental synthetic chemicals on thyroid function. Thyroid 8(9):827-856.
18. Buchholz DR, Paul ED, Fu L, Shi YB. 2006. Molecular and developmental analyses of thyroid hormone receptor function in Xenopus laevis, the African clawed frog. Gen Comp Endocrinol 145(1):1-19.
19. Buchholz DR, Paul ED, Shi YB. 2005. Gene-specific changes in promoter occupancy by thyroid hormone receptor during frog metamorphosis, Implications for developmental gene regulation. J Biol Chem 280(50):41222-41228.
20. Canaris GJ, Morowitz NR, Mayor G, Ridgway EC. 2000. The Colorado Thyroid Disease Prevalence Study. Arch Int Med 160(4):526-534.
21. Copan CC. 1998 Correlation of mechanistic data and histopathology in the evaluation of selected toxic endpoints of the endocrine system. Toxicol Lett 102-103:405-409.
22. Capen CC. 1997. Mechanistic data and risk assessment of selected toxic and points of the thyroid gland. Toxicol Pathol 25(1):39-48.
23. Casey M, Gennings C, Carter WH, Moser VC, Simmons JE. 2004. Detecting interaction(s) and assessing the impact of component subsets in a chemical mixture using fixed-ratio mixture ray designs. J Agric Biol Environ Stat 9(3):339-361.
24. Centers for Disease Control and Prevention. 2007. Interpreting and managing blood lead levels below 10 μg/dL in children and reducing childhood exposures to lead: recommendations of CDC's Advisory Committee on Childhood Lead Poisoning Prevention. MMWR Recomm Rep 56(RR-8):1-16.
25. Craft ES, DeVito MJ, Crofton KM. 2002. Comparative responsiveness of hypothyroxinemia and hepatic enzyme induction in Long-Evans rats versus C57BL/6J mice exposed to TCDD-like and phenobatbital-like, pclychlorinated biphenyl congeners. Toxicol Sci 68(2):372-380.
26. Crofton KM. 2004. Developmental disruption of thyroid hormone: correlations with hearing dysfunction in rats. Risk Anal 24(6):1665-1671.
27. Crofton KM. 2008. Thyroid disrupting chemicals mechanisms and mixtures. Int J Androl 31(2):209-223.
28. Crofton KM, Craft ES; Hedge JM, Gennings C, Simmons, JE, Carchman RA, et al. 2005. Thyroid-hormone-disrupting chemicals: evidence lor dose-dependent additivity or synergism. Environ Health Perspect 113:1549-1554.
29. Crofton KM, Ding D, Padich R, Taylor M, Henderson D. 2000. Hearing loss following exposure during development to polychlorinated biphenyls: a cochlear site of action. Hear Res 144(1-2):196-204.
30. Crofton KM, Zoeller RT. 2005. Mode of action: neurotoxicity induced by thyroid hormone disruption during development - hearing loss resulting from exposure to PHAHs. Crit Rev Toxicol 35(8-9):757-769.
31. Danzi S, Dubon P, Klein I. 2005. Effect of serum triiodo-thyronine on regulation of cardiac gene expression: role of histone acetylation. Am J Physiol Heart Circ Physiol 289(4):H1506-H15l1.
32. Daston GP, Cook JC, Kavlock RJ. 2003. Uncertainties for endocrine disrupters: our view on progress. Toxicol Sci 74:245-252.
33. Desaulniers D, Leingartner K, Musicki B, Yagminas A, Xiao GH, Cole J, et al. 2003. Effects of postnatal exposure to mixtures of non-ortho-PCBs, PCDDs, and PCDFs in prepubertal female rats. Toxical Sci 75(2):468-480.
34. De Vito M, Biegel L, Brouwer A, Brown S, Brucker-Davis F, Cheek AD, et al. 1999. Screening methods for thyroid hormone disruptors. Environ Health Perspect 107:407-415.
35. Doerge DR, Sheehan DM. 2002. Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect 110(suppl 3):349-353.
36. Dullaart RP, de Vries R, Roozendaal C, Kobold AC, Sluiter WJ. 2007. Carotid artery intima media thickness is inversely related to serum free thyroxine in euthyroid subjects. Clin Endocrinol (Oxf) 67(5):668-673.
37. Feron VJ, Groten JP. 2002. Toxicological evaluation of chemical mixtures. Food Chem Toxical 40(6):825-839.
38. Gauger KJ, Kato Y, Haraguchi K, Lehmler HJ, Robertson LW, Bansal R, et al. 2004. Polychlorinated biphenyls (PCBs) exert thyroid hormone-like effects in the fetal rat brain but do not bind to thyroid hormone receptors. Environ Health Perspect 112:516-523.
39. Gennings C, Carter WH Jr, Campain JA, Bae D, Yang RSH. 2002. Statitical analysis of interactive cytotoxicity in human epidermal keratinocytes following exposure to a mixture of four Metals. J Agric Biol Environ Sci 7(1):58-73.
40. Gilbert ME, Sui L. 2008. Developmental exposure to perchlorate alters synaptic transmission in hippocampus of the adult rat Environ Health Perspect 116:752-760.
41. Goldey ES, Kehn LS, Lau C, Rehnberg GL, Crofton KM. 1995a. Developmental exposure to polychlorinated biphenyls (Aroclor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats. Toxicol Appl Pharmacol 135(1):77-88.
42. Goldey ES, Kehn LS, Rehnberg GL, Crofton KM. 1995b. Effects of developmental hypothyroidism on auditory and motor function in the rat. Toxicol Appl Pharmacol 135(1):67-76.
43. Goncharov A, Haase RF, Santiago-Rivera A, Morse G, McCaffrey RJ, Rej R, et al. 2008. High serum PCBs are associated with elevation of serum lipids and cardiovascular disease in a Native American population. Environ Res 106(2):226-239.
44. Goodman JH, Gilbert ME. 2007. Modest thyroid hormone insufficiency during development induces a cellular malformation in the corpus callosum: a model of cortical dysplasia. Endocrinology 148(6):2593-2597.
45. Grover GJ, Mellstrom K, Malm J. 2005. Development of the thyroid hormone receptor beta-subtype agonist KB-141: a strategy for body weight reduction and lipid lowering with minimal cardiac side effects. Cardiovasc Drug Rev 23(2):33-148.
46. Guo GL, Choudhuri S, Klaassen CD. 2002. Incluction profile of rat organic anion transporting polypeptide 2 (OATP2) by prototypical drug-metabolizing enzyme inducers that activate gene expression through ligand-activated transcription factor pothways. J Pharmacol Exp Ther 300(1):206-212.
47. Haddow JE. 2005. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 106(1):198-199.
48. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. 1999. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341(8):549-555.
49. Haddow JE, Palomaki GE, Williams J. 2002. Thyroid-stimulating-hormone concentrations and risk of hypothyroidism. Lancet 360(9350):2081-2082.
50. Hansen PS, Brix TH, Sorensen TI, Kyvik KO, Hegedus L. 2004. Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. J Clin Endocrinol Metab 89(3):1181-1187.
51. Haws LC, Su SH, Harris M, Devito MJ, Walker NJ, Farland WH, et al. 2006. Development of a refined database of mammalian relative potency estimates for dioxin-like compounds. Toxicol Sci 89(1):4-30.
52. Herbstman JB, Sjodin A, Apelberg BJ, Witter FR, Halden RU, Patterson DG, et al. 2008. Birth delivery mode modifies the associations between prenatal polychlorinated biphenyl (PCB) and polybrominated diphenyl ether (PBDE) and neonatal thyroid hormone levels. Environ Health Perspect 116:1376-1382.
53. Hertzberg RC, Teuschler LK 2002. Evaluating quantitative formulas for dose-response assessment of chemical mixtures. Environ Health Perspect 110(suppl 6):965-970.
54. Heyland A, Moroz LL. 2005. Cross-kingdom hormonal signaling: an insight from thyroid hormone functions in marine larvae. J Exp Biol 208(pt 23):4355-4361.
55. Heyland A, Reitzel AM, Hodin J. 2004. Thyroid hormones determine developmental mode in sand dollars (Echinodermata: Echinoidea). Evol Dev 6(6):382-392.
56. Hill RN, Crisp TM, Hurley PM, Rosenthal SL, Singh DV. 1998. Risk assessment of thyroid follicular cell tumors. Environ Health Perspect 106:447-457.
57. 3) glucuronidation. Toxicol Sci 55(1):78-84.
58. Hurley PM. 1998. Made of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents. Environ Health Perspect 106:437-445.
59. Jansen J, Friesema EC, Kester MH, Milici C, Reeser M, Gruters A, et al. 2007. Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine. J Clin Endocrinol Metab 92(6):2378-2381.
60. Jigorel E, Le Vee M, Boursier-Neyret C, Parmentier Y, Fardel O. 2006. Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos 34(10):1756-1763.
61. Khan MA, Fenton SE, Swank AE, Hester SD, Williams A, Wolf DC. 2005. A mixture of ammonium perchlorate and sodium chlorate enhances alterations of the pituitary-thyroid axis caused bythe individual chemicals in adult male F344 rats. Toxicol Pathol 33(7):776-783.
62. Khan MA, Hansen LG. 2003. Ortho-substituted polychlorinated biphenyl (PCB) congeners (95 or 101) decrease pituitary response to thyrotropin releasing hormone. Toxicol Lett 144(2):173-182.
63. Kitamura S, Suzuki T, Sanoh S, Kohta R, Jinno N, Sugihara K, et al. 2005. Comparative study of the endocrine-disrupting activity of bisphenol A and 19 related compounds. Toxicol Sci 84(2):249-259.
64. Klammer H, Schlecht C, Wuttke W, Gotthardt I, Kohrle J, Jarry H. 2007. Effects of a 5-day treatment with the UV-filter octyl-methoxycinnamate (OMC) on the function of the hypothalamo-pituitary-thyroid function in rats. Toxicology 238(2-3):192-199.
65. Kliewer SA, Goodwin B, Willson TM. 2002. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 23(5):687-702.
66. Kodavanti PR, Mundy WR, Tilson HA, Harry GJ. 1993. Effects of selected neuroactive chemicals on calcium transporting systems in rat carebellum and on survival of cerebellar granule cells. Fundam Appl Toxicol 21(3):308-316.
67. Kodavanti PR, Ward TR. 1998. Interactive effects of environmentally relevant polychlorinated biphenyls and dioxins on [3H]phorbol ester binding in rat cerebellar granule cells. Environ Health Perspect 106:479-486.
68. Kooistra L, Crawford S, van Bear AL, Brouwers EP, Pop VJ. 2006. Neonatal effects of maternal hypothyroxinemia during early pregnancy. Pediatrics 117(1):161-167.
69. Kretschmer XC, Baldwin WS. 2005. CAR and PXR: xenosensors of endocrine disrupters? Chem Biol Interact 155(3):111-128.
70. Kroes R, Kleiner J, Renwick A. 2005. The threshold of toxicological concern concept in risk assessment. Toxicol Sci 86(2):226-230.
71. Krude H, Schutz B, Biebermann H, von Moers A, Schnabal D, Neitzel H, et al. 2002. Choreoathetosis, hypothytoidism, and pulmonary alterations due to human NKX2-1 haplo-insufficiency. J Clin Invest 109(4):475-480.
72. Landrigan PJ, Garg A. 2002. Chronic effects of toxic environmental exposures on children's health. J. Toxicol 40(4):449-456.
73. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, et al. 2005. Low-level environmental lead exposure and children's intellectual function: in international pooled analysis. Environ Health Perspect 113:894-899.
74. Lans MC, Klasson-Wehler E, Willemsen M, Meussen E, Safe S Brouwer A. 1993. Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-p-dioxins and -dibenzofurans with human transthyretin. Chem Biol Interact 88(1):7-21.
75. LeBlanc GA, Olmstead AW. 2004. Correspondence: evaluating the toxicity of chemical mixtures. Environ Health Perspect 112:A729-A730.
76. Lei J, Nowbar S, Mariash CN, Ingbar DH. 2003. Thyroid hormone stimulates Na-K-ATPase activity and its plasma membrane insertion in rat alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 285(3):L762-L772.
77. Liu L, Klaassen CD. 1996. Regulation of hepatic sulfotransferases by steroidal chemicals in rats. Drug Metab Dispos 24(8):854-858.
78. Longnecker MP, Wolff MS, Gladen BC, Brock JW, Grandjean P, Jacobson JL, et al. 2003. Comparison of polychlorinated biphenyl levels across studies of human neurodevelopment. Environ Health Perspect 111:65-70.
79. McLanahan ED, Campbell JL Jr, Ferguson DC, Harmon B, Hedge JM, Crofton KM, et al. 2007. Low-dose effects of ammonium perchlorate on the hypothalamic-pituitary-thyroid axis of adult male rats pretreated with PCB126. Toxicol Sci 97(2):308-317.
80. McNabb FM. 2006. Avian thyroid development and adaptive plasticity. Gen Comp Endocrinol 147(2):93-101.
81. Meeker JD, Altshul L, Hauser R. 2007. Serum PCBs, p,p'-DDE and HCB predict thyroid hormone levels in men. Environ Res 104(2):296-304.
82. Mendelson CR, Boggaram V. 1991. Hormonal control of the surfactant system in fetal lung. Annu Rev Physiol 53:415-440.
83. Michalopoulou G, Alevizaki M, Piperingos G, Mitsibounas D, Mantzos E, Adamopoulos P, et al. 1998. High serum cholesterol levels in persons with "high-normal" TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol 138:141-145.
84. Miyazaki W, Iwasaki T, Takeshita A, Tohyama C, Koibuchi N. 2008. Identification of the functional domain of thyroid hormone receptor responsible for polychlorinated biphenyl-mediated suppression of its action in vitro. Environ Health Perspect 116:1231-1236.
85. Moriyama K, Tagami T, Akamizu T, Usui T, Saijo M, Kanamoto N, et al. 2002. Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 87(11):5185-5190.
86. Morreale de Escobar G. 2003. Maternal hypothyroxinemia versus hypothyroidism and potential neurodevelopmental. Ann Endocrinol (Paris) 64(1):51-52.
87. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. 2000. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia. J Clin Endocrinol Metab 85(11):3975-3987.
88. Morse DC, Groen D, Veerman M, van Amerongen CJ, Koeter HB, Smits van Prooije AE, et al. 1993. Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats. Toxicol Appl Pharmacol 122(1):27-33.
89. Mumtaz MM, Sipes IG, Clewell HJ, Yang RS. 1993. Risk assessment of chemical mixtures: biologic and toxicologic issues. Fundam Appl Toxicol 21(3):258-269.
90. National Research Council. 2005. Health Implications of Perchlorate Ingestion. Washington, DC:National Academies Press.
91. Oerbeck B, Reinvang I, Sundet K, Heyerdahl S. 2007. Young adults with severe congenital hypothyroidism: cognitive event related potentials (ERPs) and the significance of an early start of thyroxine treatment. Scand J Psychol 48(1):61-67.
92. Oerbeck B, Sundet K, Kase BF, Heyerdahl S. 2003. Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults. Pediatrics 112(4):923-930.
93. Osman F, Gammage MD, Franklyn JA. 2001. Thyroid disease and its treatment: short-term and long-tem cardiovascular consequences. Curr Opin Pharmacol 1(6):626-631.
94. Petrick JS, Klaassen CD. 2007. Importance of hepatic induction of constitutive androstane receptor and other transcription factors that regulate xenobiotic metabolism and transport. Drug Metab Dispos 35(10):1806-1815.
95. Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ. 2003. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 59(3):282-288.
96. Pop VJ, Kuijpens JL, van Baar AL, Verkerk G, van Son MM, de Vijlder JJ, et al. 1999. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 50(2):149-155.
97. Pop VJ, Vulsma T. 2005. Maternal hypothyroxinaemia during (early) gestation. Lancet 365(9471):1604-1606.
98. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU. 2007. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function and quality of life in subclinical hypothyroidism: randomised, crossover trial. J Clin Endocrinol Metab 92:1715-1723.
99. Rice DC. 2000. Identification of functional domains affected by developmental exposure to methylmercury: Faroe Islands and related studies. Neurotoxicology 21(6):1039-1044.
100. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC. 2006. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med 119(7):541-551.
101. Rose G. 1981. Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 282(6279):1847-1851.
102. Rose G. 1985. Sick individuals and sick populations. Int J Epidemiol 14(1):32-38.
103. Rose G, Day S. 1990. The population mean predicts the number of deviant individuals. Br Med J (Clin Res Ed) 301(6759):1031-1034.
104. Rose SR, Brown RS, Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, et al. 2006. Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics 117(6):2290-2303.
105. Rubel EW. 1978. Ontogeny of structure and function in the vertebrate auditory system. In: Handbook of Sensory Physiology, Vol 9 (Jacobson M, ed). Berlin: Springer-Verlag, 135-237.
106. Schantz SL, Widholm JJ, Rice DC. 2003. Effects of PCB exposure on neuropsychological function in children. Environ Health Perspect 111:357-576.
107. Schettler T. 2001. Toxic threats to neurologic development of children. Environ Health Perspect 109(suppl 6):813-816.
108. Schmutzler C, Bacinski A, Gotthardt I, Huhne K, Ambrugger P, Klammer H, et al. 2007. The ultraviolet filter benzophenone 2 interferes with the thyroid hormone axis in rats and is a potent in vitro inhibitor of human recombinant thyroid peroxidase. Endocrinology 148(6):2835-2844.
109. Schrenk D. 1998. Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics. Biochem Pharmacol 55(8):1155-1162.
110. Schroder-van der Elst JP, van der Heide D, Rokos H, Kohrle J, Morreale de Escobar G. 1997. Different tissue distribution, elimination, and kinetics of thyroxine and its conformational analog, the synthetic flavonoid EMD'49209 in the rat. Endocrinology 138(1):79-84.
111. Schuetz EG, Brimer C, Schuetz JD. 1998. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. Mol Pharmacol 54(6):1113-1117.
112. Schuur AG, Legger FF, van Meeteren ME, Moonen MJ, van Leeuwen-Bol I, Bergman A, et al. 1998. In vitro inhibition of thyroid hormone sulfation by hydroxylated metabolites of halogenated aromatic hydrocarbons. Chem Res Toxicol 11:1075-1081.
113. Seegal RF. 1996. Epidemiological and laboratory evidence of PCB-induced neurotoxicity. Crit Rev Toxicol 26:709-737.
114. Seegal RF, Bush B, Brosch KO. 1991. Sub-chronic exposure of the adult rat to Aroclor 1254 yields regionally-specific changes in central dopaminergic function. Neurotoxicology 12:55-65.
115. Sharlin DS, Tighe D, Gilbert ME, Zoeller RT. 2DO8. The balance between oligodendrocyte and astrocyte production in major white matter tracts is linearly related to serum total thyroxine. Endocrinology 149(5):2527-2536.
116. Staudinger J, Liu Y, Madan A, Habeebu S, Klaassen CD. 2001. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos 29(11):1467-1472.
117. Steinmaus C, Miller MD, Howd R. 2007. Impact of smoking and thiocyanate on perchlorate and thyroid hormone associations in the 2001-2002 National Health and Nutrition Examination Survey. Environ Health Perspect 115:1333-1338.
118. Stoykov I, Zandieh-Doulabi B, Moorman AF, Christoffels V, Wiersinga WM, Bakker O. 2006. Expression pattern and ontogeoesis of thyroid hormone receptor isoforms in the mouse heart. J Endocrinol 189(2):231-245.
119. Tabb MM, Kholodovych V, Grun F, Zhou C, Welsh WJ, Blumberg B. 2004. Highly chlorinated PCBs inhibit the human xenobiotic response mediated by the steroid and xenobiotic receptor (SXR). Environ Health Perspect 112:163-169.
120. Teuschler LK. 2007. Deciding which chemical mixtures risk assessment methods work best for what mixtures. Toxicol Appl Pharmacol 223(2):139-147.
121. Tonacchera M, Pinchera A, Dimida A, Ferrarini E, Agretti P, Vitti P, at al. 2004. Relative potencies and additivity of perchlorate, thiocyanate, nitrite, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid 14(12):1012-1019.
122. Trasande L, Schechter 6, Haynes KA, Landrigan PJ. 2006. Applying cost analyses to drive policy that protects children: mercury as a case study. Ann NY Acad Sci 1076:911-923.
123. U.S. EPA. 1985.'Costt and Benefits of Reducing Lead in Gasoline. EPA-230-05-85-006. Washington, DC:U.S. Environmental Protection Agency.
124. U.S. EPA. 2000. Supplementary Guidance for Conducting Health Risk Assessment of Chemical Mixtures. EPA/630/R-00/002. Washington, DC:U.S. Environmental Protection Agency.
125. U.S. EPA. 2002. Perchlorate Environmental Contamination: Toxicological Revi ew and Risk Characterization. External Review,Draft. NCEA-1-0503. Washington, DC:U.S. Environmental Protection Agency, National Center for Environmental Assessment, Office of Research and Development.
126. Uziel A, Gabrion J, Ohresser M, Legrand C. 1981. Effects of hypothyroidisen onthe structural development of the organ of Corti in the rat. Acta Otolaryngol 92(5-6):469-480.
127. van den Berg KJ. 1990. Interaction of chlorinated phenols with thyroxine binding sites of human transthyretin, albumin and thyroid-binding globulin. Chem Biol Interact 76(1):63-75.
128. Van den Berg M, Birnbaum LS, Denison M, De Vito M, Farland W, Feeley M, et al. 2006. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 93(2):223-241.
129. Van Sande J, Massart C, Beauwens R, Schoutens A, Costagliola S, Dumont JE, et al. 2003. Anion selectivity by the sodium iodide symporter. Endocrinology 144:247-252.
130. van Tuyl M, Blommaart PE, de, Boor PA, Wert SE, Ruijteor JM, Islam S, et al. 2004. Prenatal exposure to thyroid hormone is necessary for normal postnatal development of murine heart and lungs. Dev Biol 272(1):104-117.
131. Visser TJ, van Overmeeren E, Fekkes D, Docter R, Hennemann G. 1979. Inhibition of iodothyronine 5′-deiodinase by thiolureylenes; structure - activity relationship. FEBS Lett 103(2):314-318.
132. Wade MG, Parent S, Finnson KW, Foster W, Younglai E, McMahon A, et al. 2002. Thyroid toxicity due to subchronic-exposure to a complex mixture of 16 organochlorines, lead, and cadmium. Toxicol Sci 67(2):207-218.
133. Wang LO, Falany CN, James MO. 2004. Triclosan as a substrate and inhibitor of 3′-phosphoadenosine 5′-phosphosulfate-sulfotransferase and UDP-glucuronosyl transferase in human liver fractions, Drug Metab Dispos 32(10):1162-1169.
134. Wang LO, James MO. 2006. Inhibition of sulfotransferases by xenobiotics. Cure Drug Metab 7(1):83-104.
135. Weiss B. 1997. Endocrine disruptors and sexually dimorphic behaviowrs: a question of heads and tails. Neurotoxicology 18(2):581-586.
136. Whitfield GK, Jurutka PW, Haussler CA, Haussler MR. 1999. Steroid hormone receptors evolution, ligands, and molecular basis of biologic function. J Cell Biochem (Suppl)32-33:110-122.
137. Wolff J. 1998. Perchlorate and the thyroid bland. Pharmacol Rev 50(1):89-105.
138. Yamano K, Araki K, Sekikawa K, Inui Y. 1994. Cloning of thyroid hormone receptor genes expressed in metamorphosing flounder. Bev Genet 15(4):378-382.
139. Zoeller RT. 2005. Environmental chemicals as thyroid hormone analogues: now studies indicate that thyroid hormorne receptors are targets of industrial chemical? Mol Cell Endocrinol 242(1-2)10-15.
140. Zoeller RT. 2007. Environmental chemicals impacting the thyroid: targets and consequences. Thyroid 17(9):811-817.
141. Zoeller RT, Crofton KM. 2005. Mode.of action: developmental thyroid hormone insufficiency - neurological abnormalities resulting from exposure to propylthiouracil. Crit Rev Toxicol 35(8-9):771-781.
142. Zoeller RT, Rovet J. 2004. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol 16(10):809-818.
143. Zoeller RT, Tyl RW, Tan SW. 2D07. Current and potential rodent screens and tests for thyroid toxicants. Crit Rev Toxicol 37(1):55-95.